HeartBeam, Inc. (BEATW) Financial Statements (2026 and earlier)

Company Profile

Business Address 2118 WALSH AVE., SUITE 210
SANTA CLARA, CA 95050
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:2,377,00016,189,0003,594,00013,192,000
Cash and cash equivalent2,377,00016,189,0003,594,00013,192,000
Other undisclosed cash, cash equivalents, and short-term investments    
Inventory, net of allowances, customer advances and progress billings    
Inventory    
Other undisclosed current assets393,000636,000  
Total current assets:2,770,00016,825,0003,594,00013,192,000
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization450,000256,000  
Other noncurrent assets56,00050,000  
Total noncurrent assets:506,000306,000  
Other undisclosed assets   445,000806,000
TOTAL ASSETS:3,276,00017,131,0004,039,00013,998,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,622,0001,194,0001,665,000588,000
Accounts payable531,000   
Accrued liabilities1,091,000   
Other undisclosed accounts payable and accrued liabilities  1,194,0001,665,000588,000
Total current liabilities:1,622,0001,194,0001,665,000588,000
Noncurrent Liabilities
Total liabilities:1,622,0001,194,0001,665,000588,000
Equity
Equity, attributable to parent1,654,00015,937,0002,374,00013,410,000
Common stock3,0003,0001,0001,000
Additional paid in capital57,924,00052,759,00024,559,00022,633,000
Accumulated deficit(56,273,000)(36,825,000)(22,186,000)(9,224,000)
Total equity:1,654,00015,937,0002,374,00013,410,000
TOTAL LIABILITIES AND EQUITY:3,276,00017,131,0004,039,00013,998,000

Income Statement (P&L) (USD)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating expenses(19,887,000)(15,314,000)(13,031,000)(2,285,000)
Operating loss:(19,887,000)(15,314,000)(13,031,000)(2,285,000)
Nonoperating income (expense)439,000675,00069,000(2,143,000)
Interest and debt expense    (2,165,000)
Loss from continuing operations before equity method investments, income taxes:(19,448,000)(14,639,000)(12,962,000)(6,593,000)
Other undisclosed income from continuing operations before income taxes    2,165,000
Loss from continuing operations before income taxes:(19,448,000)(14,639,000)(12,962,000)(4,428,000)
Other undisclosed loss from continuing operations    
Loss from continuing operations:(19,448,000)(14,639,000)(12,962,000)(4,428,000)
Loss before gain (loss) on sale of properties:(4,428,000)
Net loss:(19,448,000)(14,639,000)(12,962,000)(4,428,000)
Other undisclosed net income attributable to parent    
Net loss available to common stockholders, diluted:(19,448,000)(14,639,000)(12,962,000)(4,428,000)

Comprehensive Income (USD)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(19,448,000)(14,639,000)(12,962,000)(4,428,000)
Comprehensive loss, net of tax, attributable to parent:(19,448,000)(14,639,000)(12,962,000)(4,428,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: